vTv Therapeutics (VTVT) Enterprise Value (2014 - 2026)
vTv Therapeutics (VTVT) posted Enterprise Value of -$98.1 million for Q1 2026, down 10.29% sequentially from -$88.9 million in Q4 2025, and down 225.62% YoY from $78.1 million in Q1 2025.
vTv Therapeutics (VTVT) Enterprise Value (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported Enterprise Value for 13 years, with the latest figure at -$98.1 million in Q1 2026.
- Quarterly Enterprise Value fell 225.62% year-over-year to -$98.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$98.1 million (down 225.62% YoY) and the FY2025 annual result came in at -$88.9 million, down 156.07% from the prior year.
- Enterprise Value fell to -$98.1 million in Q1 2026 per VTVT's latest filing, from -$88.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at $8.9 million in Q3 2022 and troughed at -$98.5 million in Q3 2025.
- A 5-year average of -$29.0 million and a median of -$26.3 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 402.8% in 2023, then plunged 6770.7% in 2024.
- Over 5 years, Enterprise Value stood at $4.4 million in 2022, then plunged by 176.16% to -$3.4 million in 2023, then slumped by 927.49% to -$34.7 million in 2024, then plunged by 156.07% to -$88.9 million in 2025, then declined by 10.29% to -$98.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$98.1 million, -$88.9 million, and -$98.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | -86.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -86.64 Mn |
| Mar 31, 2026 | -98.09 Mn |
| Dec 31, 2025 | -88.93 Mn |
| Sep 30, 2025 | -98.50 Mn |
| Jun 30, 2025 | -26.26 Mn |
| Mar 31, 2025 | -30.12 Mn |
| Dec 31, 2024 | -34.73 Mn |
| Sep 30, 2024 | -41.69 Mn |
| Jun 30, 2024 | -41.63 Mn |
| Mar 31, 2024 | -52.37 Mn |
| Dec 31, 2023 | -3.38 Mn |
| Sep 30, 2023 | 2.51 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 785,000.00 |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 8.89 Mn |
| Jun 30, 2022 | -2.07 Mn |
| Mar 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 11.45 Mn |
| Sep 30, 2021 | 24.91 Mn |